人福醫藥(600079.SH)擬收購宜昌人福13%股權並募集配套資金不超10億元 明日復牌
格隆匯4月2日丨人福醫藥(600079.SH)公佈,公司擬通過發行股份及支付現金方式,向自然人李傑、陳小清、徐華斌購買其合計持有的宜昌人福13%股權。此次交易完成後,上市公司將持有宜昌人福80%股權,仍為宜昌人福的控股股東。
同時,公司擬向控股股東當代集團發行股份募集配套資金不超過10億元,此次募集配套資金非公開發行股票數量將不超過此次交易前公司總股本30%,募集配套資金總額將不超過此次交易中以發行股份方式購買資產的交易價格的100%。
募集配套資金扣除相關中介機構費用及相關税費後,擬用於支付現金對價、補充上市公司流動資金及宜昌人福“小容量注射製劑國際標準生產基地”項目建設。
經交易各方協商,宜昌人福13%股權具體交易價格以具有證券期貨業務資格的資產評估機構出具的評估報告的評估結果為基礎、由交易各方協商確定。
此次交易的審計及評估工作尚未完成,標的資產的評估值及交易作價均尚未最終確定,對各交易對方的股份及現金支付比例和支付數量將在交易標的審計、評估工作完成之後,由交易各方協商確定,並將在重組報告書中予以披露。
根據相關規定,經公司向上海證券交易所申請,公司股票將於2020年4月3日開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.